US 2014/0274981 A1Published application

Pharmaceutical composition of s-ketamine hydrochloride

AssigneeJanssen Pharmaceutica NV

InventorsEsther D.G. Basstanie, Johanna Bentz, Roger C.A Embrechts, Nico Rudolph Niemeijer

Life of this patent

Estimating the term…

Abstract

The present invention is directed to an aqueous formulation of S-ketamine hydrochloride, preferably for nasal administration, wherein the formulation does not contain an antimicrobial preservative.

Claims20

Dependent claims

A pharmaceutical composition comprising S-ketamine hydrochloride and water;

wherein the pharmaceutical composition does not contain an antimicrobial preservative.

Dependencies are inferred from the claim text.

Facts

Application: 14/212,424Filed 14 Mar 2014
Priority: 15 Mar 2013
Published: 18 Sep 2014
Term ends: Not estimatedThe source records don’t support an estimate.

Classification11 codes

A61K 31/135
Amines: having aromatic rings , e.g. ketamine, nortriptyline
A61K 9/0043
Galenical forms characterised by the site of application: nose
A61K 31/136
Having aromatic rings , e.g. ketamine, nortriptyline: having the amino group directly attached to the aromatic ring, e.g. benzeneamine
A61K 31/575
Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids: substituted in position 17 beta by a chain…

Family

Application61/791,237Us provisional application · filed 15 Mar 2013
US 2014/0274981 A1This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

patentgrepSearch patents

Back to results